Evidence map›Paper›PMID 30884797›Full record

ArticleMolecules (Basel, Switzerland)2019

Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties.

Claudia Finamore, Giuliana Baronissi, Silvia Marchianò, Francesco Saverio Di Leva, Adriana Carino, Maria Chiara Monti, Vittorio Limongelli, Angela Zampella, Stefano Fiorucci, Valentina Sepe

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Claudia FinamoreDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. claudia.finamore@unina.it.
Giuliana BaronissiDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. giuliana.baronissi@unina.it.
Silvia MarchianòDepartment of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy. silvia4as@hotmail.it.
Francesco Saverio Di LevaDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. francesco.dileva@unina.it.ORCID 0000-0002-2294-0656
Adriana CarinoDepartment of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy. adriana.carino@hotmail.it.ORCID 0000-0003-2341-9528
Maria Chiara MontiDepartment of Pharmacy, University of Salerno, Via Giovanni Paolo II, 132, 84084 Fisciano, Salerno, Italy. mcmonti@unisa.it.ORCID 0000-0002-1337-2909
Vittorio LimongelliDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. vittoriolimongelli@gmail.com.
Angela ZampellaDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. azampell@unina.it.
Stefano FiorucciDepartment of Surgery and Biomedical Sciences, Nuova Facoltà di Medicina, Piazza Lucio Severi, 1 - 06132 Perugia, Italy. stefano.fiorucci@unipg.it.ORCID 0000-0003-3816-4222
Valentina SepeDepartment of Pharmacy, University of Naples "Federico II", via D. Montesano 49, 80131 Naples, Italy. valentina.sepe@unina.it.ORCID 0000-0002-0169-4441

Funding

MIUR-ITALY 2015MSCKCE_003Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung 200021_163281University of Naples Federico II "Finanziamento della Ricerca in Ateneo" DR/2016/341, February 2016
6 · The paper itself

Abstract

As a cellular bile acid sensor, farnesoid X receptor (FXR) and the membrane G-coupled receptor (GPBAR1) participate in maintaining bile acid, lipid, and glucose homeostasis. To date, several selective and dual agonists have been developed as promising pharmacological approach to metabolic disorders, with most of them possessing an acidic conjugable function that might compromise their pharmacokinetic distribution. Here, guided by docking calculations, nonacidic 6-ethyl cholane derivatives have been prepared. In vitro pharmacological characterization resulted in the identification of bile acid receptor modulators with improved pharmacokinetic properties.

Indexed as

Bile Acids and SaltsCholanesGlucoseHEK293 CellsHep G2 CellsHumansLipid MetabolismMetabolic DiseasesMolecular Docking SimulationMolecular StructureProtein ConformationReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearReceptors, G-Protein-CoupledStructure-Activity RelationshipBile Acids and SaltsCholanesGlucoseGPBAR1 protein, humanReceptor, Farnesoid X-ActivatedReceptors, Cytoplasmic and NuclearReceptors, G-Protein-Coupledbile acid receptorsFXR agonistsmedicinal chemistrysteroidal scaffolds

Identifiers

PMID30884797
PMCPMC6470523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.